News Outlets Report On Issues Surrounding Ebola Vaccine Development

News outlets report on various issues surrounding the development and testing of Ebola vaccines.

Financial Times: Industry response to Ebola quickens (Ward, 10/23).
Forbes: Head of GSK Ebola Vaccine Research: “Can We Even Consider Doing A Trial?” (Munro, 10/23).
New York Times: Ebola Vaccine, Ready for Test, Sat on the Shelf (Grady, 10/23).
New York Times: Vaccine Trials for Ebola Are Planned in West Africa (Pollack, 10/23).
Reuters: Fixing ‘Ebolanomics’ in pursuit of vaccines and drugs (Kelland/Hirschler, 10/23).
ScienceInsider: Leaked documents reveal behind-the-scenes Ebola vaccine issues (Cohen/Kupferschmidt, 10/23).
Wall Street Journal: Study to Look at Blood Products From Ebola Survivors as Treatment (Loftus, 10/23).
Washington Post: As researchers develop Ebola vaccine, early human clinical trials show promise (Dennis, 10/23).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.